论文部分内容阅读
目的:关于奥曲肽与奥美拉唑联用方案治疗上消化道出血的临床效果探讨。方法:取2015年1月-2016年8月于我院单用奥美拉唑治疗上消化道出血的21例患者为本次研究对照组,另取2016年7月于我院采取奥曲肽与奥美拉唑联用方案治疗上消化道出血的20例患者作为本次研究观察组,将两组患者止血时间、住院时间、再出血率、治疗有效率作以比较。结果:观察组治疗有效率为95.0%明显高于对照组71.4%(P<0.05)。观察组止血时间、住院时间均短于对照组(P<0.05),再出血患者比重低于对照组(P<0.05)。结论:奥曲肽与奥美拉唑联用方案在上消化道出血治疗中临床治疗效果显著,短时间内快速缓解患者出血症状,降低再出血发生率,改善患者生活质量,治疗有效性与安全性兼优,值得临床广泛应用与推广。
Objective: To investigate the clinical effect of octreotide combined with omeprazole in the treatment of upper gastrointestinal bleeding. Methods: From January 2015 to August 2016 in our hospital alone omeprazole treatment of upper gastrointestinal bleeding in 21 patients for the study control group, another take 2016 July in our hospital to take octreotide and Austria Melazol in combination with the program for the treatment of upper gastrointestinal bleeding in 20 patients as the study observation group, the two groups of patients to stop bleeding time, hospitalization, rebleeding, treatment efficiency for comparison. Results: The effective rate of observation group was 95.0%, which was significantly higher than that of control group (71.4%, P <0.05). The bleeding time and hospital stay in the observation group were shorter than those in the control group (P <0.05), and the proportion of patients with rebleeding was lower than that in the control group (P <0.05). Conclusion: The combination of octreotide and omeprazole in the treatment of upper gastrointestinal bleeding in clinical treatment of significant effect, a short time to quickly alleviate the symptoms of patients with bleeding, reduce the incidence of rebleeding, improve patient quality of life, efficacy and safety of both Excellent, it is widely used in clinical and promotion.